GE HealthCare unveils Revolution™ Vibe CT system with Unlimited One-Beat Cardiac imaging and AI Solutions
GE HealthCare (GEHC) has unveiled the Revolution™ Vibe CT system, featuring Unlimited One-Beat Cardiac imaging technology. The system addresses the growing global cardiovascular disease (CVD) challenge, projected to cause over 23 million deaths by 2030.
The new CT system delivers consistent, high-quality cardiac images even in challenging cases like atrial fibrillation and heavily calcified coronaries. Key features include ECG-less Cardiac, TrueFidelity DL, SnapShot Freeze 2, and AI-powered Effortless Workflow solutions. Clinical evaluation showed the system's one-step decision tree workflow reduced exam time by 50% and saved four minutes of radiologists' time per study.
The Revolution Vibe enables facilities to expand cardiac CT capacity while improving operational efficiency. The system supports CCTA (Cardiac CT Angiography) as a first-line investigation tool for suspected coronary artery disease, aligning with NICE recommendations and recent Medicare reimbursement rate increases.
GE HealthCare (GEHC) ha presentato il Revolution™ Vibe CT system, dotato della tecnologia di imaging cardiaco Unlimited One-Beat. Questo sistema affronta la crescente sfida globale delle malattie cardiovascolari (CVD), che si prevede causino oltre 23 milioni di decessi entro il 2030.
Il nuovo sistema CT fornisce immagini cardiache di alta qualità e costanti anche in casi complessi come la fibrillazione atriale e le coronarie fortemente calcificate. Tra le caratteristiche principali ci sono il Cardiac senza ECG, TrueFidelity DL, SnapShot Freeze 2 e soluzioni per un flusso di lavoro senza sforzo alimentate dall'IA. La valutazione clinica ha mostrato che il flusso di lavoro a decisione ad un passo del sistema ha ridotto il tempo dell'esame del 50% e ha risparmiato quattro minuti di tempo ai radiologi per ogni studio.
Il Revolution Vibe consente alle strutture di ampliare la capacità di CT cardiaco migliorando al contempo l'efficienza operativa. Il sistema supporta il CCTA (Angiografia CT Cardiaca) come strumento di indagine di prima linea per sospette malattie delle arterie coronarie, in linea con le raccomandazioni NICE e i recenti aumenti delle tariffe di rimborso Medicare.
GE HealthCare (GEHC) ha presentado el sistema Revolution™ Vibe CT, que cuenta con la tecnología de imagen cardíaca Unlimited One-Beat. Este sistema aborda el creciente desafío global de las enfermedades cardiovasculares (CVD), que se prevé que causen más de 23 millones de muertes para el 2030.
El nuevo sistema CT ofrece imágenes cardíacas de alta calidad y consistentes, incluso en casos desafiantes como la fibrilación auricular y las coronarias altamente calcificadas. Las características clave incluyen Cardiac sin ECG, TrueFidelity DL, SnapShot Freeze 2 y soluciones de flujo de trabajo sin esfuerzo impulsadas por IA. La evaluación clínica mostró que el flujo de trabajo de árbol de decisión de un solo paso del sistema redujo el tiempo del examen en un 50% y ahorró cuatro minutos del tiempo de los radiólogos por estudio.
El Revolution Vibe permite a las instalaciones ampliar la capacidad de CT cardíaco mientras mejora la eficiencia operativa. El sistema apoya el CCTA (Angiografía CT Cardíaca) como herramienta de investigación de primera línea para sospechas de enfermedad de las arterias coronarias, alineándose con las recomendaciones de NICE y los recientes aumentos en las tarifas de reembolso de Medicare.
GE 헬스케어 (GEHC)는 Revolution™ Vibe CT 시스템을 공개했으며, 무제한 1회 심장 이미징 기술을 특징으로 합니다. 이 시스템은 2030년까지 2300만 명 이상의 사망을 초래할 것으로 예상되는 전 세계적인 심혈관 질환(CVD) 문제에 대응합니다.
새로운 CT 시스템은 심방 세동 및 심하게 석회화된 관상동맥과 같은 어려운 사례에서도 일관되고 고품질의 심장 이미지를 제공합니다. 주요 기능으로는 ECG 없는 심장 촬영, TrueFidelity DL, SnapShot Freeze 2 및 AI 기반의 수월한 작업 흐름 솔루션이 있습니다. 임상 평가 결과, 시스템의 일단계 의사결정 트리 작업 흐름이 검사 시간을 50% 단축하고 각 연구당 방사선과 의사의 시간을 4분 절약한 것으로 나타났습니다.
Revolution Vibe는 시설이 심장 CT 용량을 확장하면서 운영 효율성을 향상시킬 수 있도록 합니다. 이 시스템은 의심되는 관상동맥 질환에 대한 1차 조사 도구로 CCTA(심장 CT 혈관조영술)를 지원하며, NICE 권장 사항 및 최근의 메디케어 환급률 인상과 일치합니다.
GE HealthCare (GEHC) a dévoilé le système Revolution™ Vibe CT, qui intègre la technologie d'imagerie cardiaque Unlimited One-Beat. Ce système répond au défi croissant des maladies cardiovasculaires (CVD) dans le monde, qui devraient entraîner plus de 23 millions de décès d'ici 2030.
Le nouveau système CT fournit des images cardiaques de haute qualité et constantes même dans des cas difficiles comme la fibrillation auriculaire et les coronaires fortement calcifiées. Les caractéristiques clés incluent le Cardiac sans ECG, TrueFidelity DL, SnapShot Freeze 2 et des solutions de flux de travail sans effort alimentées par l'IA. L'évaluation clinique a montré que le flux de travail à arbre de décision en une étape du système a réduit le temps d'examen de 50 % et a permis d'économiser quatre minutes de temps pour les radiologues par étude.
Le Revolution Vibe permet aux établissements d'élargir leur capacité en CT cardiaque tout en améliorant l'efficacité opérationnelle. Le système soutient le CCTA (Angiographie CT cardiaque) comme outil d'investigation de première ligne pour les maladies coronariennes suspectées, conformément aux recommandations NICE et aux récentes augmentations des taux de remboursement de Medicare.
GE HealthCare (GEHC) hat das Revolution™ Vibe CT-System vorgestellt, das über die Unlimited One-Beat-Kardiabilder-Technologie verfügt. Das System geht auf die wachsende globale Herausforderung durch Herz-Kreislauf-Erkrankungen (CVD) ein, die bis 2030 voraussichtlich über 23 Millionen Todesfälle verursachen wird.
Das neue CT-System liefert selbst in herausfordernden Fällen wie Vorhofflimmern und stark verkalkten Koronarien konstante, hochwertige Herzbilder. Zu den wichtigsten Merkmalen gehören ECG-loses Herzbild, TrueFidelity DL, SnapShot Freeze 2 und KI-gestützte mühelose Arbeitsablauf-Lösungen. Die klinische Bewertung zeigte, dass der Entscheidungsbaum-Arbeitsablauf des Systems die Untersuchungszeit um 50% reduzierte und vier Minuten Zeit der Radiologen pro Studie einsparten.
Das Revolution Vibe ermöglicht es Einrichtungen, die Kapazität der Herz-CT zu erweitern und gleichzeitig die Betriebseffizienz zu verbessern. Das System unterstützt CCTA (Kardiologische CT-Angiographie) als Erstuntersuchungswerkzeug bei Verdacht auf koronare Herzkrankheit und entspricht den NICE-Empfehlungen sowie den jüngsten Erhöhungen der Medicare-Erstattungssätze.
- New CT system enables facilities to double CCTA capacity
- 50% reduction in exam time improves operational efficiency
- System designed to reduce operational costs through energy-efficient design
- Aligns with increased Medicare reimbursement rates for CCTA
- None.
Insights
GE HealthCare's launch of the Revolution Vibe CT system represents a significant strategic positioning in the rapidly growing cardiovascular imaging market. With cardiac CT procedures projected to increase by
The system's differentiated Unlimited One-Beat Cardiac imaging technology tackles longstanding challenges in cardiac CT by delivering consistent, high-quality images even in complex cases like atrial fibrillation and heavily calcified coronaries—situations that typically require repeated scans or alternative diagnostic approaches. This comprehensive cardiac solution integrates multiple AI-powered technologies that deliver measurable operational improvements:
What's particularly compelling is how GE HealthCare has aligned this product with evolving healthcare economics. The timing coincides with increased Medicare reimbursement rates for CCTA and growing adoption of NICE guidelines recommending CCTA as first-line investigation for suspected coronary artery disease. This positions the technology to capture growing procedural volumes while helping facilities expand service lines with improved operational efficiency.
For investors, this launch reinforces GE HealthCare's continued innovation in high-growth segments while addressing mounting pressures on provider productivity and cost containment. The emphasis on lifecycle cost management through energy-efficient design and Smart Subscription services also creates recurring revenue opportunities beyond the initial capital sale.
This product launch aligns perfectly with healthcare's economic transformation toward value-based care. The Revolution Vibe system addresses three critical financial pressure points simultaneously: diagnostic accuracy, operational efficiency, and expanded service capabilities.
The workflow improvements—
The reduced reliance on invasive diagnostic procedures holds substantial economic implications. By providing highly accurate non-invasive cardiac assessments, even in challenging patient populations, healthcare systems can avoid downstream costs associated with unnecessary catheterizations and their potential complications, which typically run
GE HealthCare's strategic positioning emphasizes total cost of ownership through energy-efficient design and their Smart Subscription model, which helps providers manage technology obsolescence—a persistent challenge with high-cost imaging equipment. This approach transforms the traditional capital expenditure model toward a more predictable operational expense framework that healthcare finance teams increasingly prefer.
The timing corresponds advantageously with favorable reimbursement trends, particularly Medicare's increased payment rates for CCTA studies, which improves the economic proposition for cardiovascular service line expansion. This creates a compelling multi-year growth opportunity as more healthcare facilities adopt advanced cardiac CT capabilities to meet growing demands while optimizing resource utilization.
- GE HealthCare’s Revolution Vibe CTi enables more facilities to elevate patient care by offering advanced cardiac imaging technology that helps deliver fast, accurate diagnoses, improve operational efficiency, and enhance patient outcomes.
- Cardiovascular disease (CVD) is the leading cause of death and healthcare costs worldwide,ii with research projecting it could cause over 23 million deaths by 2030.iii The average number of cardiac computed tomography (CT) procedures performed per site is expected to increase 175 percent,iv highlighting its value as a first-line imaging tool for diagnosis, treatment planning, and post-treatment follow-up.
As cardiovascular disease (CVD) continues to rise globally,vi the need for advanced diagnostic technologies like cardiac CT angiography (CCTA) becomes increasingly critical. CCTA offers a non-invasive, cost-effective, and highly sensitive method for diagnosing coronary artery disease (CAD), making it a valuable tool for clinicians. The National Institute for Health and Care Excellence (NICE) recommends CCTA as the first-line investigation for patients with chest pain due to suspected CAD, highlighting its importance in improving diagnostic certainty. vii Similarly, recent increases in Medicare reimbursement rates for CCTA are a positive step towards making this technology more accessible.
"Expanding access to CCTA is crucial for managing the rising prevalence of CVD, ensuring timely and accurate diagnoses for a larger patient population,” shares Jean-Luc Procaccini, President and CEO, Molecular Imaging and Computed Tomography, GE HealthCare. “Our introduction of Revolution Vibe underscores our commitment to this mission. The system is designed to encourage the broader adoption of and access to cardiac imaging, combining advanced technology with AI-powered solutions to deliver fast, accurate diagnoses and a more comfortable patient experience. It is designed to empower healthcare providers to offer the highest quality care, even in the most challenging cases."
For CCTA to be truly effective, the CT system must be designed to address the most difficult cardiac exams, including irregularities in heart rhythms, patients with limited cooperation, and those with calcification, stents or bypasses. These complications challenge cardiologists and radiologists alike, often leading to repeat scans, inaccurate diagnoses, heightened patient risk and dissatisfaction, and increased costs.viii, ix, x, xi, xii, xiii, xiv, xv
GE HealthCare designed Revolution Vibe to address these challenges. The ‘all in one’ system provides advanced cardiac CT solutions to help make CCTA more accessible to more facilities and patients, while also enabling greater diagnostic confidence, patient comfort, and workflow efficiency.
"Revolution Vibe has significantly enhanced our cardiac imaging capabilities, doubling our CCTA capacity while reducing scan times and improving image quality,” shares Dr. Christopher Ahlers, Radiologist and Managing Partner at Radiomed. “The advanced technology streamlines workflows, reduces reliance on invasive diagnostics, and ensures high-quality care for all patients, including those with challenging conditions. By adopting Revolution Vibe, we have improved operational efficiency, increased diagnostic confidence, and elevated patient satisfaction, positioning us at the forefront of cardiac care."
Revolution Vibe enhances cardiac capabilities, enabling Unlimited One-Beat Cardiac imaging. This advanced technology offers clear, full-heart images at low dose, improving access for patients with complex conditions like atrial fibrillation, breath-holding difficulties, heavily calcified coronaries, in-stent restenosis, and cases without an ECG trace. TrueFidelity DL images for cardiac and SnapShot Freeze 2 offer Revolution Vibe users impressive image quality with motion free images. The system also offers ECG-less Cardiac to help improve patient access and simplify preparation for exams without an ECG connection, making it ideal for situations where speed is a priority or when the ECG signal is unavailable.
Effortless Cardiac Workflow also optimizes the system for cardiac scans, leveraging AI to automatically select protocols and position the patient – optimizing scanning time and making it easy to use for every user, even junior or inexperienced technologists. In a clinical evaluation, the one-step decision tree workflow helped reduce exam time by 50 percent, freeing up four minutes of radiologists’ time per study.xvi It also helped reduce the patient preparation process by up to five minutes per scan.xvi Much of this time is saved due to reduced positioning time, minimized usage of beta blockers, and eliminating the need for an ECG connection when the cardiac exam needs to be prioritized for patient access and speed.
Finally, Revolution Vibe is designed to help healthcare facilities expand their service lines and manage lifecycle costs effectively, driving topline growth. With the growing need for cardiac CT, the system’s versatility and ability to handle increased cardiac exams and general imaging needs make it accessible to more facilities.
Beyond initial costs, Revolution Vibe offers energy-efficient design, extensive training, fleet management, and Smart Subscription, ensuring facilities stay updated with the latest technology. This innovative technology maximizes operational efficiency, enhances staff expertise, and delivers better patient outcomes, making it a wise long-term investment.
For more information on Revolution Vibe, please visit gehealthcare.com. Those attending the American College of Cardiology (ACC) 2025 meeting in
About GE HealthCare Technologies Inc.
GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient’s journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a
GE HealthCare is proud to be among 2025 Fortune World’s Most Admired Companies™.
Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.
i Revolution Vibe is CE marked and 510(k) pending with the
ii Shapiro MD et al. Eur J Radiol. 2008;66(1):37–41. doi:10.1016/j.ejrad.2007.05.006.
iii Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. (2012) 380:2095–128. 10.1016/S0140-6736(12)61728-0. https://pubmed.ncbi.nlm.nih.gov/23245604/
iv IMV. 2023 CT Market Outlook Report (p. 45).
v Walter, M. (2024, November 8). “a huge win”: CMS significantly increases Medicare payments for cardiac CT. Cardiovascular Business. https://cardiovascularbusiness.com/topics/cardiac-imaging/cms-increases-medicare-payments-cardiac-ct-ccta.
vi World Health Organization. Cardiovascular diseases (CVDs). June 11, 2021. Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed February 2023
vii Moss AJ et al. The Updated NICE Guidelines: Cardiac CT as the First-Line Test for Coronary Artery Disease. Curr Cardiovasc Imaging Rep (2017) 10: 15.
viii Shapiro MD et al. EurJ Radiol. 2008;66(1):37–41.
ix Pannu HK et al. J Comput Assist Tomogr. 2008 Mar-Apr;32(2):247-51.
x Graaf D et al. American Journal of Cardiology. 2010;105(6):767–772.
xi Techasith T et al. J Cardiovasc Comput Tomogr. 2011;5(4):255–263.
xii Ghoshhajra BB et al. Am J Med. 2012;125(8):764–772.
xiii Hamid S et al. Am J Emerg Med. 2010;28(4):494–498.
xiv Cotarlan V et al. Am J Cardiol. 2013;111(5):661–666.
xv Hoffmann U et al. Am Heart J. 2012;163(3):330-338.
xvi GE HealthCare case study. “Revolution Vibe: A new vision for heart at Radiomed.”
View source version on businesswire.com: https://www.businesswire.com/news/home/20250328986429/en/
GE HealthCare Media Contact:
Margaret Steinhafel
M +1 608 381 8829
margaret.steinhafel@gehealthcare.com
Source: GE HealthCare
FAQ
What are the key features of GE HealthCare's new Revolution Vibe CT system (GEHC)?
How much time does the Revolution Vibe CT system save in clinical evaluations?
What specific cardiac conditions can the GEHC Revolution Vibe CT system handle?
When will GE HealthCare (GEHC) formally unveil the Revolution Vibe CT system?
